These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26020483)

  • 1. Assessment of Promoter Hypermethylation and Expression Profile of P14ARF and MDM2 Genes in Patients With Pterygium.
    Arish M; Kordi-Tamandani DM; Sangterash MH; Poyandeh R
    Eye Contact Lens; 2016 Jan; 42(1):e4-7. PubMed ID: 26020483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel approach to investigation of the pathogenesis of pterygium based on assessment of promoter hyper-methylation and expression profile of CTLA4 gene: A credible report of CTLA4 gene expression in human eye tissue.
    Ebrahimi ME; Kordi-Tamandani DM; Arish M
    Gene; 2016 Jun; 583(2):130-133. PubMed ID: 26899867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer.
    Kang MY; Lee BB; Ji YI; Jung EH; Chun HK; Song SY; Park SE; Park J; Kim DH
    Cancer; 2008 Apr; 112(8):1699-707. PubMed ID: 18327804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of the p16 gene promoter in pterygia and its association with the expression of DNA methyltransferase 3b.
    Chen PL; Cheng YW; Chiang CC; Tseng SH; Chau PS; Tsai YY
    Mol Vis; 2006 Nov; 12():1411-6. PubMed ID: 17149367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 mRNA expression in the p53 pathway may predict the potential of invasion and liver metastasis in colorectal cancer.
    Kondo I; Iida S; Takagi Y; Sugihara K
    Dis Colon Rectum; 2008 Sep; 51(9):1395-402. PubMed ID: 18607552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations.
    Barekati Z; Radpour R; Kohler C; Zhang B; Toniolo P; Lenner P; Lv Q; Zheng H; Zhong XY
    Hum Mol Genet; 2010 Aug; 19(15):2936-46. PubMed ID: 20466735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wip1 over-expression correlated with TP53/p14(ARF) pathway disruption in human astrocytomas.
    Wang P; Rao J; Yang H; Zhao H; Yang L
    J Surg Oncol; 2011 Nov; 104(6):679-84. PubMed ID: 21695702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between gastric cancer and gene amplification of p14 and mdm2].
    Sun LP; Jiang NJ; Fu W; Xue YX; Zhao YS
    Ai Zheng; 2004 Jan; 23(1):36-9. PubMed ID: 14720371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
    Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2.
    Esteller M; Cordon-Cardo C; Corn PG; Meltzer SJ; Pohar KS; Watkins DN; Capella G; Peinado MA; Matias-Guiu X; Prat J; Baylin SB; Herman JG
    Cancer Res; 2001 Apr; 61(7):2816-21. PubMed ID: 11306450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma.
    Zhang C; Guo X; Zhang L; Lu Z; Ma N; Cheng Y; Shen F; Zhang B; Wu M; Wei L
    J Surg Oncol; 2008 Nov; 98(6):462-8. PubMed ID: 18683194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of c-Myc in pterygium and cultured pterygial cells.
    Cui D; Pan Z; Zhang S; Zheng J; Huang Q; Wu K
    Clin Exp Ophthalmol; 2011 Nov; 39(8):784-92. PubMed ID: 22050566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma.
    Ishida E; Nakamura M; Ikuta M; Shimada K; Matsuyoshi S; Kirita T; Konishi N
    Oral Oncol; 2005 Jul; 41(6):614-22. PubMed ID: 15975525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of methylation patterns and expression profiles of p14ARF gene in patients with oral squamous cell carcinoma.
    Kordi-Tamandani DM; Moazeni-Roodi A; Rigi Ladez MA; Hashemi M; Birjandian E; Torkamanzehi A
    Int J Biol Markers; 2010; 25(2):99-103. PubMed ID: 20586029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma.
    Wang Y; Cheng J; Xu C; Liu S; Jiang S; Xu Q; Chen X; Zhuang H; Lu F
    Liver Int; 2012 Mar; 32(3):420-8. PubMed ID: 22192146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P14ARF deficiency and its correlation with overexpression of p53/MDM2 in sporadic vestibular schwannomas.
    Chen Y; Wang ZY; Wu H
    Eur Arch Otorhinolaryngol; 2015 Sep; 272(9):2227-34. PubMed ID: 24964769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA regulation of MDM2-p53 loop in pterygium.
    Teng Y; Yam GH; Li N; Wu S; Ghosh A; Wang N; Pang CP; Jhanji V
    Exp Eye Res; 2018 Apr; 169():149-156. PubMed ID: 29360447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma.
    Su PF; Lee TC; Lin PJ; Lee PH; Jeng YM; Chen CH; Liang JD; Chiou LL; Huang GT; Lee HS
    Int J Cancer; 2007 Sep; 121(6):1257-64. PubMed ID: 17534893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological significance of promoter hypermethylation of p14/ARF gene: relationships to p53 mutational status in Tunisian population with colorectal carcinoma.
    Chaar I; Amara S; Elamine OE; Khiari M; Ounissi D; Khalfallah T; Ben Hmida A; Mzabi S; Bouraoui S
    Tumour Biol; 2014 Feb; 35(2):1439-49. PubMed ID: 24065196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.